WallStreetZenWallStreetZen

NASDAQ: TGTX
Tg Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Tg Therapeutics earnings were $60.5M for the trailing 12 months ending Jun 30, 2025, with -39.7% growth year over year. The latest TGTX earnings report on Jun 30, 2025 announced Q2 2025 earnings of $28.2M, up 457.1% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TGTX reported annual earnings of $23.4M, with 84.5% growth.

TGTX past earnings growth

How has TGTX's earnings growth performed historically?

Company
-39.71%
Industry
31.19%
Market
30.19%
TGTX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
TGTX's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

TGTX earnings history

Current Revenue
$454.1M
Current Earnings
$60.5M
Current Profit Margin
13.3%

TGTX Return on Equity

Current Company
26.1%
Current Industry
-9.6%
Current Market
26.6%
TGTX's Return on Equity (26.1%)... subscribe to Premium to read more.
High Return on Equity Performance

TGTX undefined

Current Company
9.6%
Current Industry
0.1%
TGTX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TGTX announces earnings.

TGTX undefined

Current Company
18.37%
Current Industry
7.8%
TGTX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TGTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TGTX$97.52M$60.46M-39.71%$0.41
CYTK-$566.29M-$615.26MN/A-$5.29
ABVXN/AN/AN/AN/A
CRSP-$444.86M-$467.80MN/A-$5.41
KRYS$175.01M$146.73M+35.54%$5.11
View Top Biotech Stocks

Tg Therapeutics Earnings Reports & History FAQ

What were Tg Therapeutics's earnings last quarter?

On TGTX's earnings call on Invalid Date, Tg Therapeutics (NASDAQ: TGTX) reported Q2 2025 earnings per share (EPS) of $0.19, up 280% year over year. Total TGTX earnings for the quarter were $28.19 million. In the same quarter last year, Tg Therapeutics's earnings per share (EPS) was $0.05.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.

Is Tg Therapeutics profitable or losing money?

As of the last Tg Therapeutics earnings report, Tg Therapeutics is currently profitable. Tg Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $60.46 million, a 36.82% decrease year over year.

What was TGTX's earnings growth in the past year?

As of Tg Therapeutics's earnings date in Invalid Date, Tg Therapeutics's earnings has grown -39.71% year over year. This is 70.9 percentage points lower than the US Biotechnology industry earnings growth rate of 31.19%. TGTX earnings in the past year totalled $60.46 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.